Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David R Lally

Showing results (31-40 of 42) with videos related to

Pageof 5
Sort By:
Ophthalmology. Retina|May 29, 2024
Screen Failures in Clinical Trials in RetinaNasiq Hasan, Kunaal Mehrotra, Carl J Danzig, et al.
International Journal of Retina and Vitreous|November 17, 2016
Expanded spectral domain-OCT findings in the early detection of hydroxychloroquine retinopathy and changes following drug cessationDavid R Lally, Jeffrey S Heier, Caroline Baumal, et al.
Eye (London, England)|May 26, 2023
Correction: Avacincaptad pegol for geographic atrophy secondary to age-related macular degeneration: 18-month findings from the GATHER1 trialSunil S Patel, David R Lally, Jason Hsu, et al.
Eye (London, England)|March 25, 2023
Avacincaptad pegol for geographic atrophy secondary to age-related macular degeneration: 18-month findings from the GATHER1 trialSunil S Patel, David R Lally, Jason Hsu, et al.
Ophthalmology Science|June 17, 2024
Phase I DAVIO Trial: EYP-1901 Bioerodible, Sustained-Delivery Vorolanib Insert in Patients With Wet Age-Related Macular DegenerationSunil Patel, Philip P Storey, Mark R Barakat, et al.
Ophthalmology. Retina|May 8, 2024
Vision Loss Reduction with Avacincaptad Pegol for Geographic Atrophy: A 12-Month Post Hoc Analysis of the GATHER1 and GATHER2 TrialsCarl J Danzig, Arshad M Khanani, Peter K Kaiser, et al.
Ophthalmic Surgery, Lasers & Imaging Retina|February 17, 2025
Incomplete RPE and Outer Retinal Atrophy (iRORA) Development in Eyes With Fellow-eye Neovascular Age-related Macular DegenerationHanna Choi, Giulia Corradetti, Sophiana Lindenberg, et al.
Ophthalmology|December 17, 2025
Avacincaptad pegol for geographic atrophy secondary to age-related macular degeneration: 2-year efficacy and safety results from the GATHER2 phase 3 trialArshad M Khanani, Carl J Danzig, Jeffrey S Heier, et al.
Archives of Ophthalmology (Chicago, Ill. : 1960)|August 12, 2009
Metastasis of uveal melanoma millimeter-by-millimeter in 8033 consecutive eyesCarol L Shields, Minoru Furuta, Archana Thangappan, et al.
Lancet (London, England)|September 11, 2023
Efficacy and safety of avacincaptad pegol in patients with geographic atrophy (GATHER2): 12-month results from a randomised, double-masked, phase 3 trialArshad M Khanani, Sunil S Patel, Giovanni Staurenghi, et al.
Pageof 5

Showing results (31-40 of 42) with videos related to

Sort By:
Pageof 5
Ophthalmology. Retina|May 29, 2024
Screen Failures in Clinical Trials in RetinaNasiq Hasan, Kunaal Mehrotra, Carl J Danzig, et al.
International Journal of Retina and Vitreous|November 17, 2016
Expanded spectral domain-OCT findings in the early detection of hydroxychloroquine retinopathy and changes following drug cessationDavid R Lally, Jeffrey S Heier, Caroline Baumal, et al.
Eye (London, England)|May 26, 2023
Correction: Avacincaptad pegol for geographic atrophy secondary to age-related macular degeneration: 18-month findings from the GATHER1 trialSunil S Patel, David R Lally, Jason Hsu, et al.
Eye (London, England)|March 25, 2023
Avacincaptad pegol for geographic atrophy secondary to age-related macular degeneration: 18-month findings from the GATHER1 trialSunil S Patel, David R Lally, Jason Hsu, et al.
Ophthalmology Science|June 17, 2024
Phase I DAVIO Trial: EYP-1901 Bioerodible, Sustained-Delivery Vorolanib Insert in Patients With Wet Age-Related Macular DegenerationSunil Patel, Philip P Storey, Mark R Barakat, et al.
Ophthalmology. Retina|May 8, 2024
Vision Loss Reduction with Avacincaptad Pegol for Geographic Atrophy: A 12-Month Post Hoc Analysis of the GATHER1 and GATHER2 TrialsCarl J Danzig, Arshad M Khanani, Peter K Kaiser, et al.
Ophthalmic Surgery, Lasers & Imaging Retina|February 17, 2025
Incomplete RPE and Outer Retinal Atrophy (iRORA) Development in Eyes With Fellow-eye Neovascular Age-related Macular DegenerationHanna Choi, Giulia Corradetti, Sophiana Lindenberg, et al.
Ophthalmology|December 17, 2025
Avacincaptad pegol for geographic atrophy secondary to age-related macular degeneration: 2-year efficacy and safety results from the GATHER2 phase 3 trialArshad M Khanani, Carl J Danzig, Jeffrey S Heier, et al.
Archives of Ophthalmology (Chicago, Ill. : 1960)|August 12, 2009
Metastasis of uveal melanoma millimeter-by-millimeter in 8033 consecutive eyesCarol L Shields, Minoru Furuta, Archana Thangappan, et al.
Lancet (London, England)|September 11, 2023
Efficacy and safety of avacincaptad pegol in patients with geographic atrophy (GATHER2): 12-month results from a randomised, double-masked, phase 3 trialArshad M Khanani, Sunil S Patel, Giovanni Staurenghi, et al.
Pageof 5